MYBL2 has been shown to be important factor in prostate cancer progression as a very recent study introduces it as a driver of prostate cancer plasticity, while an earlier study reported that MYBL2 is upregulated in castration-resistant prostate cancer (CRPC) [20, 21]. This evidence concerns the gene MYBL2 and prostate carcinoma.